Showing 19,421 - 19,440 results of 36,050 for search '(( significant decrease decrease ) OR ( significant ((levels increased) OR (greatest decrease)) ))', query time: 0.71s Refine Results
  1. 19421

    Knockdown of <i>fhplk1</i> disrupts growth and cell proliferation in juvenile <i>Fasciola hepatica in vitro.</i> by Paul McCusker (634425)

    Published 2025
    “…<b>(C)</b> Mean # EdU<sup>+</sup> nuclei ±SEM significantly decreased after four weeks of <i>fhplk1</i> dsRNA treatments in juvenile <i>F. hepatica</i> (n ≥ 15 for each treatment; Mann-Whitney U test). …”
  2. 19422

    Opioid consumption data. by Wali U. Pirzada (22278071)

    Published 2025
    “…</p><p>Results</p><p>The mean pre-ERAS prescription was 341 MMEs (range: 25–7200 MMEs), which decreased to 151 MMEs (range: 25–2400 MMEs) post-ERAS implementation (p < .001), following all surgeries. …”
  3. 19423

    Prescription data. by Wali U. Pirzada (22278071)

    Published 2025
    “…</p><p>Results</p><p>The mean pre-ERAS prescription was 341 MMEs (range: 25–7200 MMEs), which decreased to 151 MMEs (range: 25–2400 MMEs) post-ERAS implementation (p < .001), following all surgeries. …”
  4. 19424

    Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

    Published 2025
    “…</p><p>Results</p><p>The mean pre-ERAS prescription was 341 MMEs (range: 25–7200 MMEs), which decreased to 151 MMEs (range: 25–2400 MMEs) post-ERAS implementation (p < .001), following all surgeries. …”
  5. 19425

    Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

    Published 2025
    “…</p><p>Results</p><p>The mean pre-ERAS prescription was 341 MMEs (range: 25–7200 MMEs), which decreased to 151 MMEs (range: 25–2400 MMEs) post-ERAS implementation (p < .001), following all surgeries. …”
  6. 19426

    Characteristics of included studies. by Rong Pi (21743379)

    Published 2025
    “…Studies have consistently linked occupational fatigue to decreased productivity, heightened error rates, and compromised decision-making abilities, posing significant risks to both individual nurses and healthcare organizations. …”
  7. 19427

    Sensitivity analysis for acute fatigue subscale. by Rong Pi (21743379)

    Published 2025
    “…Studies have consistently linked occupational fatigue to decreased productivity, heightened error rates, and compromised decision-making abilities, posing significant risks to both individual nurses and healthcare organizations. …”
  8. 19428

    Factors related to nurses’ occupational fatigue. by Rong Pi (21743379)

    Published 2025
    “…Studies have consistently linked occupational fatigue to decreased productivity, heightened error rates, and compromised decision-making abilities, posing significant risks to both individual nurses and healthcare organizations. …”
  9. 19429

    Sensitivity analysis for inter-shift subscale. by Rong Pi (21743379)

    Published 2025
    “…Studies have consistently linked occupational fatigue to decreased productivity, heightened error rates, and compromised decision-making abilities, posing significant risks to both individual nurses and healthcare organizations. …”
  10. 19430

    Selection flow chart of study participants. by Jiamin Yan (13214770)

    Published 2025
    “…In contrast, these associations were not statistically significant among those with ideal sleep duration (heating: HR: 1.13, 95% CI: 0.77–1.65, P = 0.537; cooking: HR: 1.28, 95% CI: 0.90–1.81, P = 0.165).…”
  11. 19431

    Trial design. by Llum Páez (22553360)

    Published 2025
    “…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”
  12. 19432

    Schedule of the trial. by Llum Páez (22553360)

    Published 2025
    “…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”
  13. 19433

    Clinical symptoms scoring system. by Llum Páez (22553360)

    Published 2025
    “…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”
  14. 19434

    Tumoral Nanovesicles-Loaded Magnetotactic Bacteria for Tumor-Targeted Therapy under a Swing Magnetic Field by Changyou Chen (2476)

    Published 2025
    “…Finally, it is revealed that the NVs-loaded AMB-1 induced a decrease in cellular viability and significantly inhibited the growth of tumors <i>in vivo</i> under the sMF. …”
  15. 19435

    Raw data. by Adrian Bartoszek (20826922)

    Published 2025
    “…In the PTZ-induced seizure model, the application of CAF in doses over 50 mg/L resulted in a decrease in the average movement. TPM ( > 50 μM) significantly protected larvae against the PTZ. …”
  16. 19436

    Tumoral Nanovesicles-Loaded Magnetotactic Bacteria for Tumor-Targeted Therapy under a Swing Magnetic Field by Changyou Chen (2476)

    Published 2025
    “…Finally, it is revealed that the NVs-loaded AMB-1 induced a decrease in cellular viability and significantly inhibited the growth of tumors <i>in vivo</i> under the sMF. …”
  17. 19437

    Calibration curve of the ketone mixture (C4-C9). by Hong Lan (61112)

    Published 2025
    “…The results indicated that DLSMC demonstrated increased sweetness, saltiness, and umami compared to raw buffalo milk, along with heightened levels of nitrogen oxides, methane, alcohols, aldehydes, ketones, and sulfur-containing compounds. …”
  18. 19438

    The signal peak of VOCs detected by HS-GC-IMS. by Hong Lan (61112)

    Published 2025
    “…The results indicated that DLSMC demonstrated increased sweetness, saltiness, and umami compared to raw buffalo milk, along with heightened levels of nitrogen oxides, methane, alcohols, aldehydes, ketones, and sulfur-containing compounds. …”
  19. 19439

    Differential metabolites between groups A and D. by Hong Lan (61112)

    Published 2025
    “…The results indicated that DLSMC demonstrated increased sweetness, saltiness, and umami compared to raw buffalo milk, along with heightened levels of nitrogen oxides, methane, alcohols, aldehydes, ketones, and sulfur-containing compounds. …”
  20. 19440

    Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

    Published 2025
    “…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”